drugset / Trial / NCT03880357
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To demonstrate the superiority of the efficacy of the test and reference products over that of the placebo control in the treatment of scalp psoriasis.
Timeline
- Start
- 2018-10-22
- Primary completion
- 2019-03-15
- Completion
- 2019-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Betamethasone | Other / unclassified | — | Topical |
| Comparator | Calcipotriol | Small molecule | 0.005 % | Topical |
| Comparator | betamethasone dipropionate | Small molecule | 0.064 % | Topical |